Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
about
Macrolides for chronic asthmaMacrolides for chronic asthmaLow-dose, long-term macrolide therapy in asthma: An overviewEnvironmental contributions to the allergic asthma epidemic.The microbiome in asthmaRole of infection in the development and exacerbation of asthmaMacrolide immunomodulation of chronic respiratory diseases.Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis.A trial of clarithromycin for the treatment of suboptimally controlled asthma.Macrolides for the long-term management of asthma--a meta-analysis of randomized clinical trials.Asthma, airway biology, and nasal disorders in AJRCCM 2001.Recommendation for optimal management of severe refractory asthma.Clarithromycin targets neutrophilic airway inflammation in refractory asthma.Pharmacotherapy of severe asthmaChlamydia pneumoniae infections in asthma: clinical implications.Antibiotics in asthma.Advances in the management of Chlamydia pneumoniae infections.Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.Role of macrolide therapy in chronic obstructive pulmonary disease.Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.Bacteria and asthma: more there than we thought.Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma.Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.The role of anti-infectives in the treatment of refractory asthma.Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children.Atypical pathogen infection in adults with acute exacerbation of bronchial asthma.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.The transition of sputum inflammatory cell profiles is variable in stable asthma patients.The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities.Atypical bacteria and macrolides in asthmaMaintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
P2860
Q24187182-E0A76513-60BC-4C93-8D43-DA4564B6E37CQ24246506-06FF073F-A254-4419-A09F-2E9741052286Q24806416-4182C86D-06AA-4911-87AC-7986005238CFQ24812202-986E04EF-A523-425C-A686-2972F428CEF8Q28080434-4E8C38C4-2D20-4F98-993F-421A51004194Q28394320-DBCFADC2-F5B5-4E27-8F24-47A4106A49C6Q33270407-6E472071-FE46-4D0F-92FC-DF0ABE5D3A01Q33782854-496C4716-B680-49C6-91DE-69BD312E9531Q33983140-1DC0B5F6-58AE-4352-864F-F49B0BE4A19CQ34004492-510F3770-6E84-48E6-B07F-5672C15814F5Q34179660-6A3BD6A0-F0DD-4E84-9911-8DE623295397Q34360438-F8E5B451-229E-4B2A-8289-9D20C740BA99Q34550135-C74BE3FD-C751-413B-A187-76E63BB3239FQ34620187-EAE554DA-9AB2-49A5-A7E7-29040F111B19Q34703625-8C776A18-2626-4A41-A1F8-DCFEDB34BBC5Q35322603-D0D49EC5-1A12-443A-9225-398D467590ACQ35627745-D2F7D9F3-8E2A-459B-9C5E-AE9FB5EC15A9Q35652273-E77DB1D8-F0D0-4CF9-8CA6-362726386B8DQ35917262-7A150FA9-7FA4-4C29-A292-CE75650FF110Q36165742-E328719D-393E-4F9C-8C26-7AD4EBF68AB4Q36282322-B337B7F9-4F1C-4DC6-8C60-B249F13C7EF7Q36376519-45CFEDF2-D1DB-432E-9EF0-11D450D2FB10Q36991115-1188BA0B-1350-489E-8CA1-5E823C142628Q37319950-3D642C48-2DAA-413E-9E77-FCFE5F5A723EQ37332181-D3EC399F-1CE0-41D4-93D6-D0D5795C0D58Q37593123-1F6946BE-7A17-4CE5-8C6E-554FB51E61A1Q37691452-5C8DB645-D661-4471-B952-CD001622D16CQ37841594-AC745849-2EF2-4618-A33F-0B4CFFFE8939Q37852394-61555F2C-6C5D-488D-AAF3-50BAD004D759Q37858665-84E3BB8F-C626-4D49-B05D-CB14765BEF1AQ37860762-04E84255-5F7C-4AE6-A868-8BAD5E406664Q37864015-6C116D4D-16BA-4EB7-B6CD-7257D2435845Q37865216-24BA8B01-44A7-4EF5-A9D1-3CF736FA4F12Q37870844-277A11D3-26AE-4574-9D29-4A9C9DA37EECQ37959271-C740779F-857C-42A2-9B48-BF1DDF02C98CQ38406118-54F9513E-F597-42A3-A566-1524DECF2D39Q38622649-6B6C5964-E068-4204-9CC0-7ADC70B8A4D1Q39267966-0A2C2C1C-2374-4319-BA9D-631B0F3EC59DQ40518030-E545EB20-6626-4636-8454-D8422F4C2B16Q42596283-7F0BB167-F9BB-4193-B959-DDFF32244AFB
P2860
Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@en
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@nl
type
label
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@en
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@nl
prefLabel
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@en
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@nl
P2093
P2860
P1476
Trial of roxithromycin in subj ...... ion with Chlamydia pneumoniae.
@en
P2093
Jenkins CR
Mullins PR
Rubinfeld AR
P2860
P304
P356
10.1164/AJRCCM.164.4.2011040
P407
P577
2001-08-01T00:00:00Z